Company: EHC
Filing Date: 2025-04-24
Form Type: 8-K
Source: 0000785161-25-000018
Chunk: 1

Company: Encompass Health Corp
Filing Date: 2025-04-24
Form: 8-K
Item: Item 5.02
Chunk 1
---
Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Certain Officers.

On April 24, 2025, Encompass Health issued a press release announcing the appointment of Patrick W. Tuer as Executive Vice President and Chief Operating Officer, a copy of which is attached to this report as Exhibit 99.3.

Mr. Tuer, age 41, has held a number of leadership positions with the Company. Mr. Tuer has served as Group President since August 1, 2023, overseeing three of the Company’s geographic operating regions, consisting of a total of 69 hospitals. Prior to that, he served as Northeast Regional President beginning in March 2021 and as Regional Vice President, Operations beginning in November 2018. Before joining Encompass Health, he held leadership roles with both acute and post-acute hospital companies. Mr. Tuer serves on the board of directors of the American Medical Rehabilitation Providers Association.

Mr. Tuer’s current compensation arrangements are set forth below:

  Element of Total Direct Compensation                                  
  Annual Base Salary                                      $450,000      
  Target Senior Management Bonus Plan Opportunity         65% of base   
  Target Long-term Equity Incentive Plan Opportunity      150% of base  

The structure of the incentive awards and other benefits are subject to substantially the same terms and conditions as those of the Company’s other senior vice presidents, which are also discussed in more detail in the Executive Compensation section of the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 1, 2025. The Compensation and Human Capital Committee of the Board of Directors of Encompass Health will address Mr. Tuer’s compensation associated with his promotion at its next regularly scheduled meeting.

The Company has not entered into a written employment agreement with Mr. Tuer. There are no family relationships between Mr. Tuer and any of the directors or executive officers identified in the proxy or other arrangements or understandings pursuant to which he was selected as an officer, other than any arrangements or understandings with persons acting solely as officers of the Company. Since January 1, 2024, there has not been, nor is there currently proposed, any non-compensation transaction or series of similar transactions between Mr. Tuer and the Company in which the amount involved exceeds $120,000.

ITEM 7.01. Regulation FD Disclosure.